PRODUCT INFORMATION
Description
WLSEAGPVVTVRALRGTGSW is a cardiomyocyte-specific peptide (CMP). When this peptide is expressed on the surface of exosomes, it improves their specific uptake by heart cells. This peptide has been shown to reduce cardiomyocyte apoptosis in vitro and increase cardiac retention in in vivo models, making it a key tool for research into cardiac-targeted molecular delivery.
Molecular Weight
2256.44
Purity
> 95%
Formula
C₉₉H₁₅₃F₃N₂₈O₂₉
Product Type
Targeting Peptide
Sequence
Trp-Leu-Ser-Glu-Ala-Gly-Pro-Val-Val-Thr-Val-Arg-Ala-Leu-Arg-Gly-Thr-Gly-Ser-Trp
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
